rs201393544
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_181882.3(PRX):c.3656C>T(p.Pro1219Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000238 in 1,611,212 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_181882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.3656C>T | p.Pro1219Leu | missense_variant | Exon 7 of 7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.3941C>T | p.Pro1314Leu | missense_variant | Exon 7 of 7 | NP_001398056.1 | ||
PRX | XM_017027047.2 | c.3554C>T | p.Pro1185Leu | missense_variant | Exon 4 of 4 | XP_016882536.1 | ||
PRX | NM_020956.2 | c.*3861C>T | 3_prime_UTR_variant | Exon 6 of 6 | NP_066007.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000109 AC: 27AN: 248462Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134824
GnomAD4 exome AF: 0.000245 AC: 358AN: 1458976Hom.: 0 Cov.: 33 AF XY: 0.000244 AC XY: 177AN XY: 725970
GnomAD4 genome AF: 0.000164 AC: 25AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74432
ClinVar
Submissions by phenotype
not provided Uncertain:3
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) In multiple individuals, this variant has been seen where an alternate explanation for disease was also identified, suggesting this variant is unlikely to cause disease. Polyphen and MutationTaster predict this amino acid change may be damaging to the protein. -
The P1219L variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The 1000 Genomes Project reports P1219L was observed in 1/198 (0.5%) alleles from individuals of European background in Utah. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. The P1219L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Based on the currently available information, it is unclear whether the P1219L variant is a pathogenic mutation or a rare benign variant. -
- -
Charcot-Marie-Tooth disease Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.P1219L variant (also known as c.3656C>T), located in coding exon 4 of the PRX gene, results from a C to T substitution at nucleotide position 3656. The proline at codon 1219 is replaced by leucine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 4 Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1219 of the PRX protein (p.Pro1219Leu). This variant is present in population databases (rs201393544, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 32376792). ClinVar contains an entry for this variant (Variation ID: 245707). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at